LT

LENZ Therapeutics

LENZ
NASDAQHealth Care

Recent Patents

lenz
almost 2 years ago

Filed a patent for "aceclidine derivatives, compositions thereof and methods of use thereof" on Thu, May 18, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for the treatment of presbyopia" on Thu, June 22, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for the treatment of eye conditions" on Thu, October 5, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "methods for the treatment of presbyopia" on Thu, August 10, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for storage stable ophthalmic drugs" on Thu, December 28, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for the treatment of presbyopia" on Thu, December 14, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for the treatment of presbyopia" on Thu, December 14, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for the treatment of presbyopia" on Thu, December 21, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for the treatment of presbyopia" on Thu, December 28, 2023

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for storage stable ophthalmic drugs" on Thu, March 21, 2024

New US Patent
lenz
almost 2 years ago

Filed a patent for "compositions and methods for non-genotoxic conditioning" on Mon, August 29, 2022

New US Patent
lenz
almost 2 years ago

Filed a patent for "methods for genotyping gene-edited hematopoietic stem cells" on Wed, November 2, 2022

New US Patent
lenz
almost 2 years ago

Filed a patent for "methods for genotyping gene-edited hematopoietic stem cells" on Tue, November 15, 2022

New US Patent
lenz
almost 2 years ago

Filed a patent for "methods and compositions for production of genetically modified primary cells" on Thu, April 18, 2024

New US Patent
lenz
almost 2 years ago

Filed a patent for "methods to genetically engineer hematopoietic stem and progenitor cells for red cell specific expression of therapeutic proteins" on Thu, May 16, 2024

New US Patent
lenz
2 years ago

Filed a patent for "methods and compositions for production of genetically modified primary cells" on Thu, March 23, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...